Lung Cancer Clinical Trials | Norton Healthcare Louisville, Ky.

Lung Cancer Clinical Trials

Norton Cancer Institute is at the forefront of cancer treatment research. Our lung cancer clinical trials give patients access to new and innovative treatments.

Current clinical trials often include studies for non small cell lung cancer and innovative immunotherapy approaches.

Learn more about participating in a clinical trial at Norton Healthcare.

Active lung cancer clinical trials at Norton Cancer Institute include:

Lung Cancer

A Pilot, Open-Label, Multi-Center, Multi-Dose Study of GRN-1201 Added to Pembrolizumab in Subjects with PD-L1+ Non-Small Cell Lung Cancer

Lung Cancer

A Phase II, Multicenter, Randomized, Open-Label, Controlled Study of M7824 versus Pembrolizumab as a First line Treatment in Patients with PD-L1 Expressing Advanced Non-small Cell Lung Cancer

Lung Cancer

Phase 2, Open-Label Safety and Efficacy Study of Telisotuzumab Vedotin (ABBV-399) in Subjects with Previously Treated c-Met+ Non-Small Cell Lung Cancer

Lung Cancer

REPLATINUM: A Phase 3, Controlled, Open-label, Randomized Study of RRx-001 Administered Sequentially with a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond Small Cell Lung Cancer

Lung Cancer

An open-label Phase I dose finding trial with BI 891065 alone and in combination with BI 754091 to characterise safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy in patients with advanced and/or metastatic malignancies

Lung Cancer

Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase II/III Randomized Study Of Chemoradiation Versus Chemoradiation Plus Atezolizumab

Lung Cancer

A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinum-Based Chemotherapy in Combination with Checkpoint Inh

Lung Cancer

A Phase II Multi Center Study of BGB324 in Combination with Pembrolizumab in Patients with Previously Treated Advanced Adenocarcinoma of the Lung

Lung Cancer

A Prospective Longitudinal Collection of Peripheral Blood to Support the Validation of Biomarkers as an Aid in Monitoring Disease in Patients with all Stages of Lung Cancer

Lung Cancer

A Phase 2 Study to Evaluate the Safety and Efficacy of AB122 Monotherapy, AB154 in Combination with AB122, and AB154 in Combination with AB122 and AB928 in Front-Line, Non-Small Cell Lung Cancer

Miscellaneous Malignancies

Open Label Phase 2 Study of Tisotumab Vedotin for Locally Advanced or Metastatic Disease in Solid Tumors

Miscellaneous Malignancies

A Phase 1 Study to evaluate the safety, pharmacokinetics, and pharmacodynamics of escalating doses and treatment intensification of a vaccine-based immunotherapy Regimen-2 (VBIR-2) (PF-06936308) for advanced non-small cell lung cancer and metastatic tripl

Pulmonary Nodules

A STUDY TO EVALUATE A PANEL OF BLOOD BIOMARKERS FOR USE IN PATIENTS UNDERGOING EVALUATION FOR LUNG CANCER, ONC-LN-04

Cancer – 4673

Appointments

Cancer care that isn’t too far from home.

(502) 629-HOPE (4673)


Request an Appointment Online

Clinical trials

Clinical Trials

Learn more about clinical trials at Norton Healthcare
(502) 629-3500

Emily Carr knew what the issue was — she just had to keep pushing

When Emily Carr began experiencing a baffling array of symptoms — pain when she stood up, dizziness when she leaned over, severe migraines and memory loss — she thought it could be a brain tumor. […]

Read Full Story

Raising pizza money for their mom’s cancer care team was just a start for these girls

The COVID-19 pandemic can provide angst and challenges for everyone. It can prove especially challenging for those undergoing cancer treatment and their families. Turning worry into action For 9-year-old Egan and 11-year-old Etta Hofmann, the […]

Read Full Story

Celebrating cancer survivors and giving them a care plan for a long life

June 7 is National Cancer Survivors Day — a time to celebrate the strength and courage of survivors, their families and caregivers. It’s a good time to remember that life after cancer can be fulfilling, […]

Read Full Story

New immunotherapy vaccine for glioblastoma tested at Norton Cancer Institute

Renato V. LaRocca, M.D., values the opportunity to be at the forefront of brain cancer research. As a neuro-oncologist and cancer medicine specialist with Norton Cancer Institute, Dr. LaRocca has treated many cases of glioblastoma. […]

Read Full Story

Sure, telehealth is safer, but for one patient it’s just so convenient

Like many cancer patients, Misty Aubrey’s calendar is filled with appointments. She meets regularly with her oncologist, behavioral oncologist and neurologist. To be safer during the height of the COVID-19 pandemic, she stopped meeting her […]

Read Full Story
Related Stories

Emily Carr knew what the issue was — she just had to keep pushing

When Emily Carr began experiencing a baffling array of symptoms — pain when she stood up, dizziness when she leaned over, severe migraines and memory loss — she thought it could be a brain tumor. […]

Read Full Story

Raising pizza money for their mom’s cancer care team was just a start for these girls

The COVID-19 pandemic can provide angst and challenges for everyone. It can prove especially challenging for those undergoing cancer treatment and their families. Turning worry into action For 9-year-old Egan and 11-year-old Etta Hofmann, the […]

Read Full Story

Celebrating cancer survivors and giving them a care plan for a long life

June 7 is National Cancer Survivors Day — a time to celebrate the strength and courage of survivors, their families and caregivers. It’s a good time to remember that life after cancer can be fulfilling, […]

Read Full Story

New immunotherapy vaccine for glioblastoma tested at Norton Cancer Institute

Renato V. LaRocca, M.D., values the opportunity to be at the forefront of brain cancer research. As a neuro-oncologist and cancer medicine specialist with Norton Cancer Institute, Dr. LaRocca has treated many cases of glioblastoma. […]

Read Full Story

Sure, telehealth is safer, but for one patient it’s just so convenient

Like many cancer patients, Misty Aubrey’s calendar is filled with appointments. She meets regularly with her oncologist, behavioral oncologist and neurologist. To be safer during the height of the COVID-19 pandemic, she stopped meeting her […]

Read Full Story

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.